GeminIQ Website Logo

Viewing BBIO free

Subscribe for full history, 50+ metrics, screener, watchlist...

BridgeBio Pharma, Inc.

BBIO

Companies in Pharmaceutical Preparations

BridgeBio Pharma, Inc. (BBIO) — SEC Financial Statements & Analysis

BridgeBio Pharma, Inc. (BBIO) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
One Point Seven Five Percentage Convertible Senior…
---5595-------
Two Point Two Five Percentage Convertible Senior N…
---1739748-00073700
Two Point Five Zero Percentage Convertible Senior …
----455034-00054300
A2033 Convertible Senior Notes
620---0-------
A2031 Convertible Senior Notes
565565564-5750------
A2029 Convertible Senior Notes
741741740-07390-----
A2027 Convertible Senior Notes
547547547-05450-----
Term Loan
-00--437------
Equity Securities Fv Ni
-----0000593850
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
880570643749541681266408475376505302
Receivables Long Term Contracts Or Programs
------01235259
Restricted Cash Current
-1---01391390171720
Available For Sale Securities Debt Securities Curr…
601738-0-40440031
Accounts Receivable Net Current
205139117771155---2--
Inventory Net
3327251840------
Prepaid Expense And Other Assets Current
634452603535382828242321
Assets Current
1,241798839912695721445616783478588433
Investments In Affiliates Subsidiaries Associates …
--92108128144160117-0--
Equity Method Investments
6280---144------
Property Plant And Equipment Net
55667791011121213
Operating Lease Right Of Use Asset
17876766788910
Intangible Assets Net Excluding Goodwill
272829302824252526262728
Other Assets Noncurrent
191726181718201921231920
Assets
1,3719369981,080882919665794849546655504
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
293619262810131851144
Employee Related Liabilities Current
397756373358442932573429
Operating Lease Liability Current
465555555444
Deferred Revenue Current
---111215121514676
Contract With Customer Liability Current
679--15------
Other Liabilities Current
13612093664133------
Liabilities Current
816288217176152154139134141144106110
Long Term Debt Noncurrent
---00437436435435446442440
Operating Lease Liability Noncurrent
144345567891011
Deferred Revenue Noncurrent
---1518171917204--
Contract With Customer Liability Noncurrent
121313--17------
Other Liabilities Noncurrent
00110000161213
Liabilities
3,6403,0132,9212,8592,5202,3771,8831,8761,8861,8891,8491,853
Stockholders Equity
Preferred Stock Value
000-00------
Common Stock Value
000000000000
Treasury Stock Value
----323-323-275-275-275-275-275-275-275
Treasury Stock Common Value
-406-323-323---275------
Additional Paid In Capital
2,1122,0582,0181,9811,9381,9031,8761,8511,8211,4811,4601,128
Accumulated Other Comprehensive Income Loss Net Of…
-0000000-00000
Retained Earnings Accumulated Deficit
-3,985-3,821-3,628-3,446-3,264-3,096-2,831-2,669-2,596-2,561-2,392-2,215
Stockholders Equity
-2,268-2,087-1,933-1,788-1,638-1,468-1,230-1,093-1,050-1,354-1,195-1,362
Minority Interest
101110101010111112111212
Liabilities And Stockholders Equity
1,3719369981,080882919665794849546655504
Related Party
422---------
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
252525252525252525252525
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,000
Common Stock Shares Issued
204202200199197196195194193181180168
Shares Outstanding
196195193191190190189188187175174161
Treasury Stock Common Shares
988886666666

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-1.76%4.14%----------
2025-8.46%14.58%27.70%5.18%1.71%10.26%2.24%14.53%14.47%0.34%12.36%-3.19%
20240.72%-1.37%-5.59%-3.32%2.14%-0.61%16.94%14.22%38.95%-10.42%-7.87%-7.16%
2023----7.54%-15.05%-23.46%9.88%52.53%36.11%-17.98%-20.15%-13.39%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.52
2.77
3.88
5.19
4.57
4.67
3.19
4.59
5.54
3.32
5.54
3.93
Quick Ratio
1.40
2.52
3.52
4.74
4.31
4.44
2.92
4.37
5.34
3.15
5.33
3.74
Working Capital
424.93M
509.78M
622.78M
736.42M
543.07M
566.29M
305.36M
481.87M
641.95M
333.75M
481.61M
322.76M
Leverage & Debt
Debt to Equity
-1.60
-1.45
-1.51
-1.60
-1.54
-1.63
-1.53
-1.72
-1.80
-1.41
-1.55
-1.36
Interest Coverage TTM
-
-
-
-
-30.42
-12.78
-8.16
-5.87
-5.68
-7.47
-6.90
-6.59
Debt Ratio
2.65
3.22
2.93
2.65
2.86
2.59
2.83
2.36
2.22
3.46
2.82
3.68
Efficiency & Turnover
Asset Turnover TTM
0.51
0.54
0.43
0.25
0.15
0.30
0.33
0.34
0.30
0.02
0.01
0.01
Days Sales Outstanding TTM
100.85
52.40
120.21
118.98
330.19
5.32
-
-
-
68.70
-
-
Receivables Turnover TTM
3.62
6.97
3.04
3.07
1.11
68.56
-
-
-
5.31
-
-
Per Share Metrics
Diluted EPS TTM
-3.73
-3.83
-4.16
-4.08
-3.52
-2.88
-2.36
-2.44
-3.02
-3.95
-3.79
-3.61
Free Cash Flow Per Share TTM
-2.29
-2.34
-3.06
-3.45
-2.64
-2.80
-2.40
-2.22
-3.39
-3.25
-3.05
-3.04
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
95.13%
95.82%
95.78%
96.19%
95.35%
98.25%
98.90%
98.91%
98.91%
73.71%
59.24%
29.80%
Operating Profit Margin TTM
-90.52%
-104.25%
-172.39%
-278.37%
-547.57%
-267.22%
-249.98%
-232.88%
-219.98%
-6,528.75%
-5,931.12%
-9,349.96%
Net Profit Margin TTM
-125.42%
-145.98%
-225.59%
-329.68%
-525.22%
-241.44%
-203.94%
-208.49%
-246.67%
-6,913.92%
-6,560.01%
-10,199.44%
Growth Metrics
Net Revenue Growth (1Y)
355.17%
126.26%
62.46%
7.62%
-41.71%
2,285.27%
2,209.77%
3,761.22%
181.05%
-88.02%
-89.37%
-93.74%
Net Income Growth (1Y)
8.69%
36.80%
79.71%
70.17%
24.11%
-16.70%
-28.19%
-21.07%
27.33%
32.71%
23.32%
10.21%
EPS Growth (1Y)
6.10%
32.91%
76.58%
67.55%
16.64%
-27.13%
-37.79%
-32.45%
8.76%
20.23%
11.72%
0.70%
Valuation Metrics
P/E TTM
-19.89
-19.99
-12.49
-10.58
-9.82
-9.53
-10.81
-10.40
-10.25
-10.22
-6.96
-4.77
P/B
-6.38
-7.06
-5.15
-4.60
-4.01
-3.50
-3.90
-4.35
-5.26
-4.89
-3.60
-2.03
P/S TTM
24.94
29.18
28.17
34.89
51.59
23.01
22.04
21.68
25.28
706.43
456.77
486.56
Market Cap
14.47B
14.65B
9.96B
8.23B
6.57B
5.11B
4.80B
4.75B
5.53B
6.57B
4.31B
2.76B
Enterprise Value
13.58B
14.08B
9.32B
7.48B
6.03B
4.86B
4.83B
4.78B
5.48B
6.62B
4.22B
2.90B
Calculated Values
Free Cash Flow TTM
-445.12M
-448.60M
-587.52M
-658.18M
-502.26M
-521.66M
-451.54M
-416.49M
-604.92M
-529.03M
-497.82M
-488.08M
Net Debt
-882.02M
-572.14M
-642.95M
-751.10M
-542.74M
-243.76M
28.35M
27.49M
-42.78M
51.71M
-82.42M
138.06M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-24Sale
Owner: Cook, Jennifer E.
Title: -
Shares: 37,167
Price/Share: $70.00
Value: $2,601,690.00
Shares Owned: 8,383
Relationship: Director
Ownership: Direct
2026-06-23Sale
Owner: Valantine, Hannah
Title: -
Shares: 2,196
Price/Share: $68.57
Value: $150,579.72
Shares Owned: 9,259
Relationship: Director
Ownership: Direct
2026-06-15Sale
Owner: Cook, Jennifer E.
Title: -
Shares: 90,240
Price/Share: $66.88
Value: $6,035,251.20
Shares Owned: 6,589
Relationship: Director
Ownership: Direct
2026-06-05Sale
Owner: Kumar, Neil
Title: Chief Executive Officer
Shares: 40,000
Price/Share: $68.01
Value: $2,720,400.00
Shares Owned: 515,686
Relationship: Director,Officer
Ownership: Indirect
2026-05-21Sale
Owner: Kumar, Neil
Title: Chief Executive Officer
Shares: 26,103
Price/Share: $69.30
Value: $1,808,937.90
Shares Owned: 243,327
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
95.53%
Inst. Shares: 186,080,680
Shares Outstanding: 194,789,897
2025-12-31
95.60%
Inst. Shares: 183,106,081
Shares Outstanding: 191,527,482
2025-09-30
94.11%
Inst. Shares: 180,561,956
Shares Outstanding: 191,854,152
2025-06-30
97.11%
Inst. Shares: 185,015,202
Shares Outstanding: 190,517,215
2025-03-31
95.72%
Inst. Shares: 182,002,755
Shares Outstanding: 190,145,253

Research Faster.
Invest Smarter.

BridgeBio Pharma, Inc. (BBIO) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.